Novartis Unit to Pay $195 Million in Generic-Drug Price-Fixing Case

South Africa News News

Novartis Unit to Pay $195 Million in Generic-Drug Price-Fixing Case
South Africa Latest News,South Africa Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 8 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

Sandoz, a subsidiary of Novartis, will pay a $195 million criminal penalty for fixing prices on generic drugs, the Justice Department said

WASHINGTON—Novartis AG’s Sandoz subsidiary will pay a $195 million criminal penalty for fixing prices on generic drugs, the Justice Department said Monday.

The department said Sandoz admitted it was guilty of participating in several conspiracies to rig bids and fix prices on an array of generic medicines.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Overwatch League esports team owners, investors breakdown: VC, Kraft - Business InsiderThe price to join Activision Blizzard's esports league has steadily gone up since its first season, with team owners willing to pay up to $60 million.
Read more »

Apple to pay up to $500 million to settle U.S. lawsuit over slow iPhonesApple Inc has agreed to pay up to $500 million to settle litigation accusing it ...
Read more »

Mindy Kaling Adds Frank Sinatra’s Malibu Beach House to Property PortfolioThe last couple of television series six-time Emmy nominated sitcom supernova Mindy Kaling has created have not fared terribly well. The 2018 NBC primetime series “Champions” was canceled after its…
Read more »

Home of the Week: Celebrating a Craftsman classic in Angelino HeightsHome of the Week: Celebrating a Craftsman classic in Angelino HeightsA 115-year-old Craftsman-style home in Angelino Heights has been recently restored. Asking price: $1.795 million.
Read more »

Hundreds Of Cheap, Generic Doorstops Flood Market After DoorBlocker Patent Runs OutHundreds Of Cheap, Generic Doorstops Flood Market After DoorBlocker Patent Runs OutDETROIT—Free to produce generic versions of the product after DoorBlocker’s 20-year patent ran out last month, hundreds of businesses have begun distributing cheap, off-brand doorstops to retail outlets nationwide, industry analysts confirmed Tuesday. “Now that anyone can manufacture a doorstop without fear of legal challenges from the DoorBlocker company, we can expect the market to be flooded with tons of these low-cost knockoffs of the original door-impeding device,” said market researcher Paul Holbloom, naming brands like DoorHalt, SwingLock, PropStop, and Wedge as being among those that have gone on sale in just the past few weeks. “It’s likely DoorBlocker will keep some of its most loyal customers, but I expect that in the future we’ll see many opting for doorstops that are more economical and less of a status symbol.” Holbloom added that the expiration of DoorBlocker’s patent would have no effect on the sizable segment of the market that has always held their doors open with bricks or shoes.
Read more »



Render Time: 2025-03-05 01:42:12